ESR1 and breast carcinoma: GRHL2 expression is enriched in human breast cancer stem cell-like subpopulation and is included in a 31-gene signature predictive of distant metastasis in estrogen receptor–negative breast cancer cohorts (Leth-Larsen et al., 2012).